We are excited to announce our upcoming conference engagements for the spring season, where RheumaFinder will be actively participating and showcasing our innovative solutions for the early detection of rheumatic diseases.
Biotrinity – April 1-2, London
Join us at Biotrinity in London, where our CEO, Nicolaas Fosselle, will pitch RheumaFinder’s advanced AI technology to potential investors. This event is a key opportunity to highlight our mission to revolutionize rheumatic disease detection through cutting-edge imaging and AI.
Knowledge for Growth – May 8
Our CEO will present at Knowledge for Growth, focusing on prevention in the healthtech track. This presentation will underscore the importance of early intervention in managing rheumatic diseases and improving patient outcomes.
EULAR 2025 – Barcelona
We are preparing for EULAR 2025, the largest European medical conference dedicated to rheumatology. At this event, Prof. Lennart Jans, co-founder of RheumaFinder and a distinguished Professor at the University Hospital of Ghent, will present on behalf of the University Hospital. This significant event will provide a platform to engage with leading experts and share our latest advancements in rheumatology.
HLTH Europe – June 16-19, Amsterdam
Our CEO will attend HLTH Europe in Amsterdam, participating in discussions about the future of health technology. This gathering is an excellent opportunity to explore innovations and collaborations in the healthcare sector.
ESSR Annual Meeting
Our CMO, Thomas Van Den Berghe, and CSO, Lennart Jans, will share insights on musculoskeletal radiology at the ESSR Annual Meeting. This conference is a key event for professionals in the field, offering a unique opportunity to delve into the latest advancements and research.
We look forward to connecting with industry peers, sharing our innovations, and engaging with the medical community throughout these events. Stay tuned for updates as we continue our mission to revolutionize the early detection of rheumatic diseases.
For the latest news and updates, follow us on RheumaFinder and on LinkedIn.